Why deliver a statin in form of inclusion complex with hydrophilic cyclodextrin?
In this work, the effects of simvastatin (SIM), 2-hydroxypropyl)-β-cyclodextrin (HPβCD) and their complex (SIM: HPβCD) on the structure and properties
Category: Drug delivery
The talks of webinar “Meet the Experts: Applications of Cyclodextrins in the Pharma Industries” on youtube
The webinar held on Apr. 15-16, 2021 and organized by Cyclolab received wide attantion. It was in the afternoon Central
Inhaled budesonide in the treatment of early COVID-19
The Lancet published on an open-label, parallel-group, phase 2, randomised controlled trial, on inhaled budesonide (Ramakrishnan et al. 2021). Participants
Targeting Lipid Rafts as a Strategy Against Coronavirus
Lipid rafts are functional membrane microdomains containing sphingolipids, including gangliosides, and cholesterol. These regions are characterized by highly ordered and
Results of the survey at the CycloLab’s webinar on pharmaceutical applications of cyclodextrins Day 2
During the webinar of CycloLab “Getting the best out of cyclodextrins” held on Apr.15-16, 2021, the participants could answer to
Results of the survey at the CycloLab’s webinar on the pharmaceutical applications of cyclodextrins Day 1
During the webinar of CycloLab “Getting the best out of cyclodextrins” held on Apr.15-16, 2021, the participants could answer to
Central nervous system delivery of molecules across the blood-brain barrier
Therapies targeting neurological conditions such as Alzheimer’s or Parkinson’s diseases are hampered by the presence of the blood-brain barrier (BBB).
Statistics of the webinar on pharmaceutical applications of cyclodextrins
The webinar of CycloLab “Getting the best out of cyclodextrins” was held on Apr.15-16, 2021. Out of >500 registrations over
Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: characterization of electrospun- and lyophilized formulations
Veklury™ by Gilead Sciences, Inc., containing antiviral drug, remdesivir (REM) has received emergency authorization in the USA and in Europe
Visible Light-Activatable Cyclodextrin-Conjugates for the Efficient Delivery of Nitric Oxide with Fluorescent Reporter and their Inclusion Complexes with Betaxolol
Novel multifunctional drug delivery systems were developed by the Sortino’s group [1]. βCD-NBFNO1 and βCD-NBFNO2, covalently integrating an N-nitroso amino-nitro-benzofurazan